202 related articles for article (PubMed ID: 3792668)
1. Gastric endocrine cells in omeprazole-treated and untreated patients with the Zollinger-Ellison syndrome.
Bardram L; Thomsen P; Stadil F
Digestion; 1986; 35 Suppl 1():116-22. PubMed ID: 3792668
[TBL] [Abstract][Full Text] [Related]
2. The effect of Zollinger-Ellison syndrome and omeprazole therapy on gastric oxyntic endocrine cells.
Maton PN; Lack EE; Collen MJ; Cornelius MJ; David E; Gardner JD; Jensen RT
Gastroenterology; 1990 Oct; 99(4):943-50. PubMed ID: 1697548
[TBL] [Abstract][Full Text] [Related]
3. Histopathology of the gastric oxyntic mucosa in two different patient groups during long-term treatment with omeprazole.
Hage E; Hendel L; Gustafsen J; Hendel J
Eur J Gastroenterol Hepatol; 2003 Jul; 15(7):781-9. PubMed ID: 12811309
[TBL] [Abstract][Full Text] [Related]
4. Argyrophil cell hyperplasia and a carcinoid tumour in the stomach of a patient with sporadic Zollinger-Ellison syndrome.
Feurle GE
Gut; 1994 Feb; 35(2):275-7. PubMed ID: 8307483
[TBL] [Abstract][Full Text] [Related]
5. Progression of gastric enterochromaffin-like cells growth in Zollinger-Ellison syndrome and atrophic body gastritis patients.
Delle Fave G; Marignani M; Corleto VD; Angeletti S; D'Ambra G; Ferraro G; D'Adda T; Azzoni C; Jensen RT; Annibale B; Bordi C
Dig Liver Dis; 2002 Apr; 34(4):270-8. PubMed ID: 12038811
[TBL] [Abstract][Full Text] [Related]
6. Helicobacter pylori effects on gastritis, gastrin and enterochromaffin-like cells in Zollinger-Ellison syndrome and non-Zollinger-Ellison syndrome acid hypersecretors treated long-term with lansoprazole.
Hirschowitz BI; Haber MM
Aliment Pharmacol Ther; 2001 Jan; 15(1):87-103. PubMed ID: 11136282
[TBL] [Abstract][Full Text] [Related]
7. Focal oxyntic gland atrophy with endocrine cell hyperplasia in Zollinger-Ellison syndrome during omeprazole treatment.
Caruana P; Azzoni C; Bertelé A; Annibale B; Franzé A; Delle Fave G; Bordi C
Histopathology; 1992 Oct; 21(4):359-63. PubMed ID: 1398539
[TBL] [Abstract][Full Text] [Related]
8. Enterochromaffin-like (ECL) cells and their growths: relationships to gastrin, reduced acid secretion and gastritis.
Solcia E; Rindi G; Silini E; Villani L
Baillieres Clin Gastroenterol; 1993 Mar; 7(1):149-65. PubMed ID: 7682874
[TBL] [Abstract][Full Text] [Related]
9. Intramucosal cysts in the gastric body of patients with Zollinger-Ellison syndrome.
Aprile MR; Azzoni C; Gibril F; Jensen RT; Bordi C
Hum Pathol; 2000 Feb; 31(2):140-8. PubMed ID: 10685627
[TBL] [Abstract][Full Text] [Related]
10. Long-term treatment with lansoprazole for patients with Zollinger-Ellison syndrome.
Hirschowitz BI; Mohnen J; Shaw S
Aliment Pharmacol Ther; 1996 Aug; 10(4):507-22. PubMed ID: 8853754
[TBL] [Abstract][Full Text] [Related]
11. Inter-relationship between serum gastrin levels, gastric mucosal histology and gastric endocrine cell growth.
Creutzfeldt W; Lamberts R
Digestion; 1992; 51 Suppl 1():76-81. PubMed ID: 1397748
[TBL] [Abstract][Full Text] [Related]
12. Hypergastrinemia and gastric enterochromaffin-like cells.
Bordi C; D'Adda T; Azzoni C; Pilato FP; Caruana P
Am J Surg Pathol; 1995; 19 Suppl 1():S8-19. PubMed ID: 7762739
[TBL] [Abstract][Full Text] [Related]
13. Long-term efficacy and safety of omeprazole in patients with Zollinger-Ellison syndrome: a prospective study.
Maton PN; Vinayek R; Frucht H; McArthur KA; Miller LS; Saeed ZA; Gardner JD; Jensen RT
Gastroenterology; 1989 Oct; 97(4):827-36. PubMed ID: 2777040
[TBL] [Abstract][Full Text] [Related]
14. [Antisecretory drugs, hypergastrinemia and hyperplasia of enterochromaffin-like cells (ECL)].
Andriulli A; Mangia A; Lawson F
Minerva Gastroenterol Dietol; 1991; 37(3):135-40. PubMed ID: 1686409
[TBL] [Abstract][Full Text] [Related]
15. Consequences of long-term proton pump blockade: insights from studies of patients with gastrinomas.
Jensen RT
Basic Clin Pharmacol Toxicol; 2006 Jan; 98(1):4-19. PubMed ID: 16433886
[TBL] [Abstract][Full Text] [Related]
16. Gastric endocrine cell behavior in Zollinger-Ellison patients upon long-term potent antisecretory treatment.
Lehy T; Mignon M; Cadiot G; Elouaer-Blanc L; Ruszniewski P; Lewin MJ; Bonfils S
Gastroenterology; 1989 Apr; 96(4):1029-40. PubMed ID: 2925050
[TBL] [Abstract][Full Text] [Related]
17. Histomorphological characteristics of gastric mucosa in patients with Zollinger-Ellison syndrome or autoimmune gastric atrophy: role of gastrin and atrophying gastritis.
Lehy T; Roucayrol AM; Mignon M
Microsc Res Tech; 2000 Mar; 48(6):327-38. PubMed ID: 10738314
[TBL] [Abstract][Full Text] [Related]
18. Oxyntic mucosa histology in omeprazole-treated patients suffering from duodenal ulcer or Zollinger-Ellison syndrome.
Helander HF
Digestion; 1986; 35 Suppl 1():123-9. PubMed ID: 3792669
[TBL] [Abstract][Full Text] [Related]
19. Stereologic investigations of human gastric mucosa. II. Oxyntic mucosa from patients with Zollinger-Ellison syndrome.
Helander HF; Rutgersson K; Helander KG; Pisegna JP; Gardner JD; Jensen RT; Maton PN
Scand J Gastroenterol; 1992 Oct; 27(10):875-83. PubMed ID: 1439541
[TBL] [Abstract][Full Text] [Related]
20. Present experiences with omeprazole in the Zollinger-Ellison syndrome.
Lamers CB
Scand J Gastroenterol Suppl; 1986; 118():123-8. PubMed ID: 3460167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]